![]() |
|
|
Vol. 30, Issue 5, 541-547, May 2002
Department of Biomedical Sciences, University of Rhode Island,
Kingston, Rhode Island
Carboxylesterases hydrolyze numerous endogenous and foreign
compounds with diverse structures. Humans and rodents express multiple
forms of carboxylesterases, which share a high degree of sequence
identity (~70%). Alignment analyses locate in carboxylesterases several functional subsites such the catalytic triad as seen in acetylcholinesterase. The aim of this study was to determine among human and rodent carboxylesterases the immunorelatedness, overlapping substrate specificity, differential sensitivity to serine enzyme inhibitors, tissue distribution, and tumor-related expression. Six
antibodies against whole carboxylesterases or synthetic peptides were
tested for their reactivity toward 11 human or rodent recombinant carboxylesterases. The antibodies against whole proteins generally exhibited a broader cross-reactivity than the anti-peptide antibodies. All carboxylesterases hydrolyzed para-nitrophenylacetate
and para-nitrophenylbutyrate. However, the relative
activity varied markedly from enzyme to enzyme (>20-fold), and some
carboxylesterases showed a clear substrate preference.
Carboxylesterases with the same functional subsites had a similar
profile on substrate specificity and sensitivity toward
phenylmethylsulfonyl fluoride (PMSF) and paraoxon, suggesting that
these subsites play determinant roles in the recognition of substrates
and inhibitors. Among three human carboxylesterases, HCE-1 hydrolyzed
both substrates to a similar extent, whereas HCE-2 and HCE-3 showed an
opposite substrate preference. All three enzymes were inhibited by PMSF
and paraoxon, but they showed a marked difference in relative
sensitivities. Based on immunoblotting analyses, HCE-1 was present in
all tissues examined, whereas HCE-2 and HCE-3 were expressed in a
tissue-restricted pattern. Colon carcinomas expressed slightly higher
levels of HCE-1 and HCE-2 than the adjacent normal tissues, whereas the
opposite was true with HCE-3.
This article has been cited by other articles:
![]() |
G. Hoffmann, C. Funk, S. Fowler, M. B. Otteneder, A. Breidenbach, C. R. Rayner, T. Chu, and E. P. Prinssen Nonclinical Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in the Central Nervous System Antimicrob. Agents Chemother., November 1, 2009; 53(11): 4753 - 4761. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lal, J. Sukbuntherng, E. H. L. Tai, S. Upadhyay, F. Yao, M. S. Warren, W. Luo, L. Bu, S. Nguyen, J. Zamora, et al. Arbaclofen Placarbil, a Novel R-Baclofen Prodrug: Improved Absorption, Distribution, Metabolism, and Elimination Properties Compared with R-Baclofen J. Pharmacol. Exp. Ther., September 1, 2009; 330(3): 911 - 921. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Watanabe, T. Fukami, M. Nakajima, M. Takamiya, Y. Aoki, and T. Yokoi Human Arylacetamide Deacetylase Is a Principal Enzyme in Flutamide Hydrolysis Drug Metab. Dispos., July 1, 2009; 37(7): 1513 - 1520. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-R. Kim, K. Sai, T. Tanaka-Kagawa, H. Jinno, S. Ozawa, N. Kaniwa, Y. Saito, A. Akasawa, K. Matsumoto, H. Saito, et al. Haplotypes and a Novel Defective Allele of CES2 Found in a Japanese Population Drug Metab. Dispos., October 1, 2007; 35(10): 1865 - 1872. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yang, D. Shi, D. Yang, X. Song, and B. Yan Interleukin-6 Alters the Cellular Responsiveness to Clopidogrel, Irinotecan, and Oseltamivir by Suppressing the Expression of Carboxylesterases HCE1 and HCE2 Mol. Pharmacol., September 1, 2007; 72(3): 686 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tang, M. Mukundan, J. Yang, N. Charpentier, E. L. LeCluyse, C. Black, D. Yang, D. Shi, and B. Yan Antiplatelet Agents Aspirin and Clopidogrel Are Hydrolyzed by Distinct Carboxylesterases, and Clopidogrel Is Transesterificated in the Presence of Ethyl Alcohol J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1467 - 1476. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Shi, J. Yang, D. Yang, E. L. LeCluyse, C. Black, L. You, F. Akhlaghi, and B. Yan Anti-Influenza Prodrug Oseltamivir Is Activated by Carboxylesterase Human Carboxylesterase 1, and the Activation Is Inhibited by Antiplatelet Agent Clopidogrel J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1477 - 1484. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Imai, M. Taketani, M. Shii, M. Hosokawa, and K. Chiba Substrate Specificity of Carboxylesterase Isozymes and Their Contribution to Hydrolase Activity in Human Liver and Small Intestine Drug Metab. Dispos., October 1, 2006; 34(10): 1734 - 1741. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Landowski, P. L. Lorenzi, X. Song, and G. L. Amidon Nucleoside Ester Prodrug Substrate Specificity of Liver Carboxylesterase J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 572 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kubo, S.-R. Kim, K. Sai, Y. Saito, T. Nakajima, K. Matsumoto, H. Saito, K. Shirao, N. Yamamoto, H. Minami, et al. FUNCTIONAL CHARACTERIZATION OF THREE NATURALLY OCCURRING SINGLE NUCLEOTIDE POLYMORPHISMS IN THE CES2 GENE ENCODING CARBOXYLESTERASE 2 (HCE-2) Drug Metab. Dispos., October 1, 2005; 33(10): 1482 - 1487. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Imai, M. Imoto, H. Sakamoto, and M. Hashimoto IDENTIFICATION OF ESTERASES EXPRESSED IN CACO-2 CELLS AND EFFECTS OF THEIR HYDROLYZING ACTIVITY IN PREDICTING HUMAN INTESTINAL ABSORPTION Drug Metab. Dispos., August 1, 2005; 33(8): 1185 - 1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Furihata, M. Hosokawa, N. Koyano, T. Nakamura, T. Satoh, and K. Chiba IDENTIFICATION OF DI-(2-ETHYLHEXYL) PHTHALATE-INDUCED CARBOXYLESTERASE 1 IN C57BL/6 MOUSE LIVER MICROSOMES: PURIFICATION, CDNA CLONING, AND BACULOVIRUS-MEDIATED EXPRESSION Drug Metab. Dispos., October 1, 2004; 32(10): 1170 - 1177. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Song, M. Xie, H. Zhang, Y. Li, K. Sachdeva, and B. Yan THE PREGNANE X RECEPTOR BINDS TO RESPONSE ELEMENTS IN A GENOMIC CONTEXT-DEPENDENT MANNER, AND PXR ACTIVATOR RIFAMPICIN SELECTIVELY ALTERS THE BINDING AMONG TARGET GENES Drug Metab. Dispos., January 1, 2004; 32(1): 35 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Sanghani, S. K. Quinney, T. B. Fredenburg, Z. Sun, W. I. Davis, D. J. Murry, O. W. Cummings, D. E. Seitz, and W. F. Bosron Carboxylesterases Expressed in Human Colon Tumor Tissue and Their Role in CPT-11 Hydrolysis Clin. Cancer Res., October 15, 2003; 9(13): 4983 - 4991. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Xie, D. Yang, M. Wu, B. Xue, and B. Yan Mouse Liver and Kidney Carboxylesterase (M-LK) Rapidly Hydrolyzes Antitumor Prodrug Irinotecan and the N-Terminal Three Quarter Sequence Determines Substrate Selectivity Drug Metab. Dispos., January 1, 2003; 31(1): 21 - 27. [Abstract] [Full Text] [PDF] |
||||